Gilead Sciences wins reversal of $1.2B award in patent case
Share!
Business Insurance - Aug 26, 2021
A U.S. appeals court on Thursday threw out a $1.2 billion ruling against Gilead Sciences Inc., finding a patent on a cancer therapy it was accused of infringing was invalid, in a blow to rival Bristol Myers Squibb Co....
Recommended Articles